Conceptio
›
cholangiocarcinoma
Topic
cholangiocarcinoma
Knowledge-graph topic
· documents ABOUT cholangiocarcinoma across the archive
152
Documents about cholangiocarcinoma
Documents about cholangiocarcinoma
Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma
#417541
ClinicalTrials.gov
Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma
#201758
ClinicalTrials.gov
Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)
#911041
ClinicalTrials.gov
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
#811172
ClinicalTrials.gov
Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma
#872773
ClinicalTrials.gov
Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma
#805132
ClinicalTrials.gov
Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma
#917028
ClinicalTrials.gov
Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
#840747
ClinicalTrials.gov
Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial
#873440
ClinicalTrials.gov
Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations
#900490
ClinicalTrials.gov
Adebrelimab Plus S-1 for Resected Cholangiocarcinoma
#411411
ClinicalTrials.gov
A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma
#884994
ClinicalTrials.gov
Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data
#895407
ClinicalTrials.gov
Combined HAIC, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma
#913250
ClinicalTrials.gov
A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation
#812394
ClinicalTrials.gov
HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma
#154669
ClinicalTrials.gov
HAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic Cholangiocarcinoma
#217046
ClinicalTrials.gov
Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study
#867646
ClinicalTrials.gov
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
#832790
ClinicalTrials.gov
Fluorescence Image Guided Surgery in Cholangiocarcinoma
#849160
ClinicalTrials.gov
Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma
#832090
ClinicalTrials.gov
Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma
#841720
ClinicalTrials.gov
Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC)
#18584
ClinicalTrials.gov
Role of coagulation irregularities in cholangiocarcinoma: a review
#313092
Recep Tayyip Erdoğan University Institutional Repository
Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma
#806052
ClinicalTrials.gov
A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
#407709
ClinicalTrials.gov
Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements
#829811
ClinicalTrials.gov
Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor)
#890537
ClinicalTrials.gov
PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma
#238213
ClinicalTrials.gov
Minimally Invasive Pancreatoduodenectomy for Distal Cholangiocarcinoma
#811560
ClinicalTrials.gov
Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma
#383569
ClinicalTrials.gov
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic Cholangiocarcinoma
#394769
ClinicalTrials.gov
Clinical Trial of Autologous Tcm Immunotherapy in ICC
#829508
ClinicalTrials.gov
Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma
#861680
ClinicalTrials.gov
Clinical Feasibility of Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in Locally Advanced Cholangiocarcinoma
#885870
ClinicalTrials.gov
Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma
#918848
ClinicalTrials.gov
Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations
#909928
ClinicalTrials.gov
GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma
#67857
ClinicalTrials.gov
Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma
#861164
ClinicalTrials.gov
En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant Criteria
#979720
ClinicalTrials.gov
Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE
#901780
ClinicalTrials.gov
HAIC Sequential TAE Combined With Tislelizumab and Surufatinib in Unresectable Intrahepatic Cholangiocarcinoma
#858143
ClinicalTrials.gov
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
#346918
ClinicalTrials.gov
Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma
#180384
ClinicalTrials.gov
Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
#848367
ClinicalTrials.gov
Trifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With Cholangiocarcinoma
#856956
ClinicalTrials.gov
Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer
#343816
ClinicalTrials.gov
The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma
#913614
ClinicalTrials.gov
Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects With Nonresectable or Metastatic IDH1 Mutant Cholangiocarcinoma
#148775
ClinicalTrials.gov
Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma
#846393
ClinicalTrials.gov
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.